Executive All-Change: Bayer's Weinand To Join Sanofi, While Sanofi's Oelrich To Take His Place At Bayer

A head-spinning change of executives in Europe's leading pharmaceutical companies will see a new head of pharmaceuticals at Bayer and the former incumbent fetching up at Sanofi in the US.  

Office suite
New faces will be seen in executive suites at Sanofi and Bayer. • Source: Shutterstock.

Two of Europe's leading pharma companies, Sanofi and Bayer AG, have refreshed their executive line-up with personnel from the other company, in moves which will see a new head of pharmaceuticals at Germany's Bayer, and changes to the global business units (GBUs) of France's Sanofi that will produce a large primary care GBU and a new GBU focused on China and emerging markets.

The changes follow disappointing starts to 2018 for both companies; uninspiring financials and manufacturing issues have affected Bayer Also see...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Executives On The Move

More from Leadership